Skip to content

Released Aug 14, 2012, after the close

10-Q filed Aug 14, 2012, 45 days after period end · 0001193125-12-355531

Q2 2012 · 10-Q
Revenue$3.38Mno prior Q2 2011 on file+23.0% vs Q1 2012
Net Income-$15.66MN/M vs Q2 2011N/M vs Q1 2012
EPS Diluted-$0.03N/M vs Q2 2011N/M vs Q1 2012
Gross Profit$2,914,000—
Operating Cash Flowderived-$6,745,000N/M
Margins · derived
Gross margin86.2%
Net margin-463.0%

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2012Q2 2011Q2 2010
Revenue$3.38M——
Net Income-$15.66M-$3.75M-$2.14M
EPS Diluted-$0.03-$0.10-$0.12

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR